Northern California Genitourinary Cancer Research Forum (09/19/2026)

Sat, 19 Sep 2026 14:30:00 GMT

Join us for the Northern California Genitourinary Cancer Research Forum taking place at the Claremont Resort & Club, September 19, 2026!

Meeting Overview:

Clinical trials are vital to progress in oncology, offering the most promising potential therapies and, often, serving as the treatment of choice for cancer patients. However, navigating the landscape of trial enrollment—especially for genitourinary malignancies—requires a specialized, collaborative, and patient-centered approach that is rarely incorporated in standard continuing medical education.

We invite you to join us for an innovative one-day multi-disciplinary educational meeting to bridge this critical gap. This forum convenes leading academic and community clinicians and researchers to enhance collaboration, share cutting-edge science, and strategize on best practices for clinical trial participation in kidney, bladder, and prostate cancer.

Learning Objectives:

To engage in scientific exchange of in-progress and recently completed clinical trials in genitourinary malignancies.
To discuss best practices in clinical trial enrollment for genitourinary malignancies, including identifying barriers to participation, working creatively on recruitment strategies, and collaborating across institutions.
To raise awareness of available clinical trials in prostate, bladder and kidney cancer in Northern California.
To discuss multidisciplinary collaboration on clinical trials for genitourinary malignancies that involve medical oncology, urology, and/or radiation oncology partnership.

ANCO & MOASC Present: Precision Oncology Symposium (11/07/2026)

Sat, 07 Nov 2026 16:00:00 GMT

Join us for ANCO & MOASC Present: Precision Oncology Symposium 2026 taking place at the InterContinental San Francisco, November 7, 2026!

Meeting Overview:

Transforming Tumor Profiling into Targeted Patient Care.

Precision oncology is rapidly changing the landscape of cancer care. With FDA approvals shifting toward molecular features rather than disease location, personalized treatment is no longer just a goal—it’s the standard.

However, with diagnostic technologies and targeted therapies evolving at a breathtaking pace, keeping up with clinical applications remains a challenge. Join ANCO & MOASC for an immersive symposium designed to help practicing oncologists and clinical care teams bridge the gap between cutting-edge diagnostics and patient outcomes.

Learning Objectives:

By participating this meeting, attendees will learn to:

Translate complex molecular tumor profiles and tumor-agnostic FDA approvals into personalized patient treatment plans.
Navigate current challenges and adopt new therapeutic opportunities in Gastrointestinal, Genitourinary, Lung, and Breast/Gynecologic cancers.
Utilize germline data alongside somatic diagnostic findings to guide comprehensive clinical decision-making.
Identify cross-tumor challenges in precision testing and apply best practices to overcome diagnostic barriers.
Partner with patient advocates to ensure biomarker-driven care plans remain patient-centered and accessible.

ANCO upcoming events

Northern California Genitourinary Cancer Research Forum (09/19/2026)

Join us for the Northern California Genitourinary Cancer Research Forum taking place at the Claremont Resort & Club, September 19, 2026!

ANCO & MOASC Present: Precision Oncology Symposium (11/07/2026)

Join us for ANCO & MOASC Present: Precision Oncology Symposium 2026 taking place at the InterContinental San Francisco, November 7, 2026!